scholarly journals Book Review: Bad Blood – Secrets and Lies in a Silicon Valley Startup

2019 ◽  
Vol 9 (1) ◽  
pp. 15-16
Author(s):  
Emeril Santander
Keyword(s):  
Silicon Valley ◽  
Laboratory Medicine ◽  
Laboratory Diagnostics ◽  
Medical Innovation ◽  
Full Resolution ◽  
Non Fiction ◽  
Award Winning ◽  
American Laboratory

This book review appraises John Carreyrou’s non-fiction book Bad Blood. The text provides penetrating insights on Theranos, an American laboratory diagnostics company that promised to revolutionize laboratory medicine. The author’s award-winning prose relays the events leading to the eventual discovery of fraud at Theranos as well as the subsequent collapse of the company. The book can be faulted for being unripe. Publication prior to a full resolution to the Theranos affair precludes analysis of the longer-term impacts of this fraud. Notwithstanding Bad Blood’s imperfect timing, the book remains a seminal text amidst journalistic chronicles of medical innovation gone wrong.

scholarly journals Book Review: 9/11 and the War on Terror: A Documentary and Reference Guide

2017 ◽  
Vol 56 (4) ◽  
pp. 300
Author(s):  
Carla Wilson Buss
Keyword(s):  
Foreign Policy ◽  
War On Terror ◽  
Policy Research ◽  
Military History ◽  
September 11 ◽  
First Person ◽  
Reference Guide ◽  
Non Fiction ◽  
Research Institute

In the nearly sixteen years since the terrible events of September 11, 2001, nearly 13,000 non-fiction books have been written about that day. Topics range from first-person accounts to memorials to collections of documents. A new addition to the crowded field is 9/11 and the War on Terror: A Documentary and Reference Guide. The author, Paul J. Springer, is a Senior Fellow at the Foreign Policy Research Institute and Professor of Comparative Military History at the Air Command and Staff College in Alabama. His work presents excerpts of declassified documents, chosen to illustrate the effects on and between terrorism and counterterrorism. The selected material is freely available elsewhere, but in this collection the author provides a useful chronology and a short analysis of both the impetus to create the document and its effects.

scholarly journals Cost, profitability and value of laboratory diagnostics: in God we trust, all others bring data

2018 ◽  
Vol 0 (0) ◽  
Author(s):  
Giuseppe Lippi ◽  
Mario Plebani
Keyword(s):  
Laboratory Tests ◽  
Clinical Pathways ◽  
Laboratory Medicine ◽  
Scale Economy ◽  
Therapeutic Monitoring ◽  
Laboratory Diagnostics ◽  
Clinical Value ◽  
Healthcare Budget ◽  
The Impact ◽  
Diagnostic Investigations

Abstract Although laboratory tests are the most used diagnostic investigations for screening, diagnosing, prognosticating and therapeutic monitoring of most human diseases, laboratory medicine is currently seen as many other economic industries by some policymakers and administrators, and is hence subjected to scale economy and assessed accordingly, despite the incremental clinical value that laboratory tests can generate. According to a genuine economic perspective, the impact of diagnostic testing on a healthcare budget is lower than 2.5%, whilst its profitability is over 100%, a net profit margin over 7-fold larger than whatever other human industry. Even more importantly, the impact of laboratory tests on clinical outcomes is now clear and virtually incontestable, as their use will improve clinical pathways much more than any other diagnostic investigations. The many ongoing attempts to downsize the importance of laboratory medicine as costs centers, or even the concept that public laboratory services can be safely eliminated or outsourced to external private professional organizations, shall hence be challenged. Laboratory medicine not only is vital to patient care and patient flow, and will remain so for many years to come, but is also a valuable economical resource for the healthcare facilities.

Sign in / Sign up

Export Citation Format

Share Document